PAO Group Inc (PAOG)

[Tally-ho]

PAOG SCREAMS BUY - This Cannabis BioTech Could Double By Friday
August 19 2020 - 11:01AM
InvestorsHub NewsWire
Print
Share On Facebook
August 19, 2020 -- InvestorsHub NewsWire -- via NextBigTicker -- PAO Group, Inc. (USOTC: PAOG) is reported today by AmericanBULLS to be “screaming” Buy (americanbulls.com/PAOG). “The green light is on and this security is now screaming BUY. It is action time! The bullish pattern that was previously identified is finally confirmed and a BUY signal is generated. Most probably, it is the right time to participate in bullish fervor. Do not miss this bullish opportunity.”

PAOG climbed from $0.003 yesterday on high trading volume to $0.005 today as of this writing. The company is pushing a new 52 week high and just charted a MACD cross. With the company’s updated financial statement and OTC Market’s Current Information status expected as early as by the end of this week, combined with the overall biotech sector momentum, the PPS could breakout over $0.01 at any moment.

PAOG recently entered the biotech sector with a proprietary treatment for respiratory disorders derived from a patented cannabis extract. The company reports having run a trial of its proprietary treatment on COVID-19 patients that has compelled the company to apply for the Coronavirus Treatment Acceleration Program (CTAP).